ClinicalTrials.Veeva

Menu

Symptomatic Treatment of Acute Uncomplicated Diverticulitis

H

Helsinki University Central Hospital (HUCH)

Status

Completed

Conditions

Diverticulitis

Treatments

Drug: Paracetamol
Drug: Ibuprofen

Study type

Interventional

Funder types

Other

Identifiers

NCT02219698
HUS-Dnro122-2014

Details and patient eligibility

About

The purpose of this study is to determine the safety and efficacy of symptomatic treatment (i.e. without antimicrobial drugs) of acute uncomplicated diverticulitis.

Enrollment

158 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Computed tomography-diagnosed acute uncomplicated* diverticulitis

    • No abscess, fistula, obstruction and distant intra- or retroperitoneal air. Pericolic air allowed.

Exclusion criteria

  • Already commenced antimicrobial medication
  • Immunosuppression (e.g. diabetes, corticosteroid medication, immunosuppressive medication, chemotherapy, chronic liver disease)
  • Suspicion of generalized peritonitis
  • Organ dysfunction
  • Another infection requiring antimicrobial medication
  • Pregnancy
  • Age < 18 years or > 90 years
  • Missing written consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

158 participants in 1 patient group

Symptomatic treatment
Experimental group
Treatment:
Drug: Paracetamol
Drug: Ibuprofen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems